Global Compounding Pharmacies Market: Analysis By Product Type (Oral, Topical, Ophthalmic, Injectables, Others), By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, Others), End User (Adult, Pediatric, Geriatric, Veterinary), By Region

Global Compounding Pharmacies Market: Analysis By Product Type (Oral, Topical, Ophthalmic, Injectables, Others), By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, Others), End User (Adult, Pediatric, Geriatric, Veterinary), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Region (North America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, China, Japan, India, Brazil, Mexico)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies and stakeholders) and secondary research, the report aims to present the analysis of Global Compounding Pharmacies Market. The report has further analysed the Compounding Pharmacies Market by By Product Type (Oral, Topical, Ophthalmic, Injectables and Others), By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology and Others) and By End User (Adult, Pediatric, Geriatric and Veterinary). The Global Compounding Pharmacies Market has been analysed By Region (North America, Europe, Asia Pacific, ROW) and By Country (United States, Canada, United Kingdom, Germany, China, Japan, India, Brazil and Mexico) for the historical period of 2014-2018 and the forecast period of 2019-2024.

Valued at approximately USD 9689.56 million in the year 2018, the global compounding pharmacies market is being influenced by several key factors such as rising share of elderly individuals, increase in per capita expenditure on healthcare as well as rising trend of adopting personalized medicines. Furthermore, increasing population growth rate with significant share of people suffering from a slew of diseases such as cancers, cardiovascular disorders, hormonal imbalances, etc., have been propelling the demand for customized pharmaceutical products that can be most effective to their individual health conditions. Furthermore, the “one-size-fits-all” characteristic of majority of mass produced drugs means that several patients’ requirements are not met. In such circumstances, the patients often rely on the services provided by the compounding pharmacies. Above and beyond, patients utilizing personalized compounded medications often experience fewer side effects than those treated with generic medications. Within the different therapeutic areas of compounded pharmaceutical products, hormone replacement therapy and pain management remained the chief money-spinning segments. On the basis of end user, the global compounding pharmacies market is dominated by adults encompassing the age group of 19 to 64 years.

The report has covered and analysed the potential of global compounding pharmacies market and provides statistics and information on market size, shares, market attractiveness and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation.

Scope of the Report

Global Compounding Pharmacies Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Global Market – Sizing, Growth, Forecast
  • Analysis by Product Type – Oral, Topical, Ophthalmic, Injectables, Others
  • Analysis by Therapeutic Area - Hormone Replacement, Pain Management, Dermatology, Others
  • Analysis by End User - Adult, Pediatric, Geriatric, Veterinary
  • Market Attractiveness of Compounding Pharmacies Market By Product, Therapeutic Area, By End-User
Regional Compounding Pharmacies Market– North America, Europe, Asia Pacific, ROW (Actual Period: 2014-2018, Forecast Period: 2019-2024)
  • Regional Market – Sizing, Growth, Forecast
  • Analysis by Product Type – Oral, Topical, Ophthalmic, Injectables, Others
  • Analysis by Therapeutic Area - Hormone Replacement, Pain Management, Dermatology, Others
  • Analysis by End User - Adult, Pediatric, Geriatric, Veterinary
  • Regional Market Attractiveness of Compounding Pharmacies Market By Country
Country Analysis – United States, Canada, United Kingdom, Germany, India China, Japan, Brazil, Mexico (Actual Period: 2014-2018, Forecast Period: 2019-2024)
  • Compounding Pharmacies Market – Sizing, Growth, Forecast
Other Report Highlights:
  • Market Dynamics – Drivers and Restraints
  • Market Trends
  • Competitive Landscape, Company Share Analysis, Merger and Acquisitions of Key Industry Players
  • SWOT Analysis
  • Porter Five Force Analysis
  • Policy and Regulatory Landscape
  • Company Analysis – Fagron, PharMEDium, Dougherty’s Pharmacy, ITC Compounding Pharmacy, Fresenius Kabi, Clinigen Group, Absolute Pharmacy, McGuff Compounding Pharmacy Services, Inc., and Harrow Health, Inc.


1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Compounding Pharmacies Market Outlook
Table 1: Compounding Pharmacies, Flowchart
Table 2: Typical Pharmacy Compounding Operations
5. Global Compounding Pharmacies Market: Growth and Forecast
5.1 By Value (2014-2018)
Table 3: Global Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
5.2 By Value (2019-2024)
Table 4: Global Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 5: Share of People Aged 65+, 2015 and 2050F (In %)
Table 6: Distributions of persons aged 60 years or above by region in millions, 2015 and 2030F
Table 7: Projected global population (In Billions)
Table 8: Projected global population aged 60 years & above (In Billions)
Table 9: Prevalence of Cardiovascular Diseases Worldwide (In million)
Table 10: Number of people with diabetes, Worldwide, (In million), 2017 & 2045E
Table 11: Key Facts & Tables About Diabetes, 2017
Table 12: Projected increase in cases of diabetes in 2045, By region (In Percentage)
Table 13: Top 10 countries for number of adults with diabetes (20-79 years), 2017, (In Million)
Table 14: Global Burden of Cancer
Table 15: Global Prevalence of Different Type of Cancer, 2017 (In Thousands)
Table 16: Global Prevalence of Prostate Cancer (2013-2017, Thousands)
Table 17: Global Expected Healthcare Industry Outlook
Table 18: Regional Expected Healthcare Industry Growth Rate By Year 2020
Table 19: Key Factors Driving Global Healthcare Industry
Table 20: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Table 21: GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
6. Global Compounding Pharmacies Market: Segment Analysis
6.1 Global Compounding Pharmacies Market, By Product Type:
6.1.1 Global Compounding Pharmacies Market Size, By Product Type, By Value - 2018 (In %)
Table 22: Global Compounding Pharmacies Market Size, By Product Type, By Value - 2018 (%)
6.1.2 Global Compounding Pharmacies Market Size, By Product Type, By Value - 2024 (In %)
Table 23: Global Compounding Pharmacies Market Size, By Product Type, By Value - 2024F (%)
6.1.3 Global Compounding Pharmacies Market, By Oral Preparations, By Value (2014-2018)
Table 24: Global Compounding Pharmacies Market, By Oral Preparations, By Value, 2014-2018 (USD Million)
6.1.4 Global Compounding Pharmacies Market, By Oral Preparations, By Value (2019-2024)
Table 25: Global Compounding Pharmacies Market, By Oral Preparations, By Value, Forecast, 2019-2024 (USD Million)
6.1.5 Global Compounding Pharmacies Market, By Topical Preparations, By Value (2014-2018)
Table 26: Global Compounding Pharmacies Market, By Topical Preparations, By Value, 2014-2018 (USD Million)
6.1.6 Global Compounding Pharmacies Market, By Topical Preparations, By Value (2019-2024)
Table 27: Global Compounding Pharmacies Market, By Topical Preparations, By Value, Forecast, 2019-2024 (USD Million)
6.1.7 Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value (2014-2018)
Table 28: Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value, 2014-2018 (USD Million)
6.1.8 Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value (2019-2024)
Table 29: Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value, Forecast, 2019-2024 (USD Million)
6.1.9 Global Compounding Pharmacies Market, By Injectable Preparations, By Value (2014-2018)
Table 30: Global Compounding Pharmacies Market, By Injectable Preparations, By Value, 2014-2018 (USD Million)
6.1.10 Global Compounding Pharmacies Market, By Injectable Preparations, By Value (2019-2024)
Table 31: Global Compounding Pharmacies Market, By Injectable Preparations, By Value, Forecast, 2019-2024 (USD Million)
6.1.11 Global Compounding Pharmacies Market, By Other Preparations, By Value (2014-2018)
Table 32: Global Compounding Pharmacies Market, By Other Preparations, By Value, 2014-2018, (USD Million)
6.1.12 Global Compounding Pharmacies Market, By Other Preparations, By Value (2019-2024)
Table 33: Global Compounding Pharmacies Market, By Other Preparations, By Value, Forecast, 2019-2024 (USD Million)
6.1.13 Market Opportunity of Global Compounding Pharmacies Market - By Product Type
Table 34: Market Opportunity Chart of Global Compounding Pharmacies Market - By Product Type (Year-2024)
6.2 Global Compounding Pharmacies Market, By Therapeutic Area
6.2.1 Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2018 (In %)
Table 35: Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2018 (%)
6.2.2 Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2024 (In %)
Table 36: Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2024F (%)
6.2.3 Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value (2014-2018)
Table 37: Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value,2014-2018 (USD Million)
6.2.4 Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value (2019-2024)
Table 38: Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value, Forecast, 2019-2024 (USD Million)
6.2.5 Global Compounding Pharmacies Market, By Pain Management Application, By Value (2014-2018)
Table 39: Global Compounding Pharmacies Market, By Pain Management Application, By Value, 2014-2018 (USD Million)
6.2.6 Global Compounding Pharmacies Market, By Pain Management Application, By Value (2019-2024)
Table 40: Global Compounding Pharmacies Market, By Pain Management Application, By Value, Forecast, 2019-2024 (USD Million)
6.2.7 Global Compounding Pharmacies Market, By Dermatology Application, By Value (2014-2018)
Table 41: Global Compounding Pharmacies Market, By Dermatology Application, By Value, 2014-2018 (USD Million)
6.2.8 Global Compounding Pharmacies Market, By Dermatology Application, By Value (2019-2024)
Table 42: Global Compounding Pharmacies Market, By Dermatology Application, By Value, Forecast, 2019-2024 (USD Million)
6.2.9 Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value (2014-2018)
Table 43: Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value, 2014-2018 (USD Million)
6.2.10 Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value (2019-2024)
Table 44: Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value, Forecast, 2019-2024 (USD Million)
6.2.10 Market Opportunity of Global Compounding Pharmacies Market - By Therapeutic Area
Table 45: Market Opportunity Chart of Global Compounding Pharmacies Market - By Therapeutic Area (Year-2024)
6.3 Global Compounding Pharmacies Market: Analysis By End User
6.3.1 Global Compounding Pharmacies Market Size, By End User, By Value - 2018 (In %)
Table 46: Global Compounding Pharmacies Market Size, By End User, By Value - 2018 (%)
6.3.2 Global Compounding Pharmacies Market Size, By End User, By Value - 2024 (In %)
Table 47: Global Compounding Pharmacies Market Size, By End User, By Value - 2024F (%)
6.3.3 Global Compounding Pharmacies Market, By Adult End User, By Value (2014-2018)
Table 48: Global Compounding Pharmacies Market, By Adult End User, By Value, 2014-2018 (USD Million)
6.3.4 Global Compounding Pharmacies Market, By Adult End User, By Value (2019-2024)
Table 49: Global Compounding Pharmacies Market, By Adult End User, By Value, Forecast, 2019-2024 (USD Million)
6.3.5 Global Compounding Pharmacies Market, By Pediatric End User, By Value (2014-2018)
Table 50: Global Compounding Pharmacies Market, By Pediatric End User, By Value, 2014-2018 (USD Million)
6.3.6 Global Compounding Pharmacies Market, By Pediatric End User, By Value (2019-2024)
Table 51: Global Compounding Pharmacies Market, By Pediatric End User, By Value, Forecast, 2019-2024 (USD Million)
6.3.7 Global Compounding Pharmacies Market, By Geriatric End User, By Value (2014-2018)
Table 52: Global Compounding Pharmacies Market, By Geriatric End User, By Value, 2014-2018 (USD Million)
6.3.8 Global Compounding Pharmacies Market, By Geriatric End User, By Value (2019-2024)
Table 53: Global Compounding Pharmacies Market, By Geriatric End User, By Value, Forecast, 2019-2024 (USD Million)
6.3.9 Global Compounding Pharmacies Market, By Veterinary End User, By Value (2014-2018)
Table 54: Global Compounding Pharmacies Market, By Veterinary End User, By Value, 2014-2018 (USD Million)
6.3.10 Global Compounding Pharmacies Market, By Veterinary End User, By Value (2019-2024)
Table 55: Global Compounding Pharmacies Market, By Veterinary End User, By Value, Forecast, 2019-2024 (USD Million)
6.3.11 Market Opportunity of Global Compounding Pharmacies Market - By End User
Table 56: Market Opportunity Chart of Global Compounding Pharmacies Market - By End User (Year-2024)
Table 57: Global Healthcare Landscape, By Select Region
7. Global Compounding Pharmacies Market: Regional Analysis
7.1 Global Compounding Pharmacies Market Size, By Region: Breakdown (%)
7.1.1 Global Compounding Pharmacies Market Size, By Region, 2018 (%)
Table 58: Global Compounding Pharmacies Market Size, By Region, 2018 (%)
7.1.2 Global Compounding Pharmacies Market Size, By Region, 2024F (%)
Table 59: Global Compounding Pharmacies Market Size, By Region, 2024F (%)
7.2 North America Compounding Pharmacies Market: Growth and Forecast
7.2.1 By Value (2014-2018)
Table 60: North America Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.2.2 By Value (2019-2024)
Table 61: North America Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 62: North America GDP, 2012-2018 (USD Trillion)
Table 63: North America GDP per capita, current prices, 2013-2023F (In USD)
Table 64: North America, Adjusted net national income per capita, 2012-2017 (current USD)
Table 65: North America Population above 65 year, 2015, 2030F, & 2050F (In Millions)
Table 66: Prevalence of Diabetes in North America, 2017 & 2045E (In Million)
Table 67: North America, Population Projections (In Millions)
Table 68: Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds)
Table 69: North America, Cancer Incidence (In Millions)
Table 70: North America, Cancer Incidence, By Route of Administration, 2019E (In %)
Table 71: Prevalence of Obesity in United States Among Populace Aged Above 20, 2013-2017 (% of total)
Table 72: Prevalence of cardiovascular disease in North America, In million
Table 73: North America, Company Share Analysis, 2018 (In %)
7.2.3 North America Compounding Pharmacies Market- Company Share Analysis
7.2.4 By Product Type, By Value (2014-2018)
Table 74: North America Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
7.2.5 By Product Type, By Value (2019-2024)
Table 75: North America Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
7.2.6 By Therapeutic Area, By Value (2014-2018)
Table 76: North America Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
7.2.7 By Therapeutic Area, By Value (2019-2024)
Table 77: North America Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
7.2.8 By End User, By Value (2014-2018)
Table 78: North America Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
7.2.9 By End User, By Value (2019-2024)
Table 79: North America Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
7.3 North America Compounding Pharmacies Market: Country Analysis (U.S and Canada)
7.3.1 Market Attractiveness Chart of North America Compounding Pharmacies Market – By Country, By Value
Table 80: Market Opportunity Chart of North America Compounding Pharmacies Market - By Country, By Value (Year-2024)
7.3.2 North America Compounding Pharmacies Market Size, By Country, 2018 (%)
Table 81: North America Compounding Pharmacies Market, Country Share, 2018 (%)
7.3.3 North America Compounding Pharmacies Market Size, By Country, 2024F (%)
Table 82: North America Compounding Pharmacies Market, Country Share, 2024F (%)
7.3.4 U.S Compounding Pharmacies Market, By Value (2014-2018)
Table 83: U.S. Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.3.5 U.S Compounding Pharmacies Market, By Value (2019-2024)
Table 84: U.S. Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 85: U.S., Population ages 65 and above, 2014-2018 (% of total)
Table 86: Total national health expenditures, 2018
Table 87: United States, GDP, 2012-2022F (In USD Billion)
Table 88: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Table 89: United States, Number of Individuals Aged 65+, (In Million)
Table 90: U.S, Population Projections (In Millions)
7.3.6 Canada Compounding Pharmacies Market, By Value (2014-2018)
Table 91: Canada Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.3.7 Canada Compounding Pharmacies Market, By Value (2019-2024)
Table 92: Canada Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 93: Canada, GDP, 2012-2022F (In USD Billion)
Table 94: Canada, Health Care Spending, Key Facts, 2018
Table 95: Canada, Population ages 65 and above, 2014-2018 (% of total)
Table 96: Canada, Population Ageing Key Facts
Table 97: Prevalence of Diabetics in Canada, (% of Total Population) 2015 & 2045F
Table 98: Estimated Prevalence of Pre-Diabetics in Canada, (% of Total Population) 2015 & 2045F
Table 99: Canada, Population Projections (In Millions)
Table 100: Prevalence of Chronic Diseases Among Canadian Adults
7.4 Europe Compounding Pharmacies Market: Growth and Forecast
7.4.1 By Value (2014-2018)
Table 101: Europe Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.4.2 By Value (2019-2024)
Table 102: Europe Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 103: European Country Population Aged 65 and Above, 2014-2018 (% of Total)
Table 104: Euro Area, Population ages 65 years and above (% of total population), 2014-2018
Table 105: Breakdown of Total Health Expenditure in Europe, 2018 (%)
Table 106: Prevalence of Diabetes (Age 18+), 2017 & 2045E (In Million)
Table 107: North America, Company Share Analysis, 2018 (In %)
7.4.3 Europe Compounding Pharmacies Market- Company Share Analysis
7.4.4 By Product Type, By Value (2014-2018)
Table 108: Europe Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
7.4.5 By Product Type, By Value (2019-2024)
Table 109: Europe Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
7.4.6 By Therapeutic Area, By Value (2014-2018)
Table 110: Europe Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
7.4.7 By Therapeutic Area, By Value (2019-2024)
Table 111: Europe Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
7.4.8 By End User, By Value (2014-2018)
Table 112: Europe Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
7.4.9 By End User, By Value (2019-2024)
Table 113: Europe Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
7.5 Europe Compounding Pharmacies Market: Country Analysis (Germany and U.K)
7.5.1 Market Attractiveness Chart of Europe Compounding Pharmacies Market – By Country, By Value
Table 114: Market Opportunity Chart of Europe Compounding Pharmacies Market - By Country, By Value (Year-2024)
7.5.2 Europe Compounding Pharmacies Market Size, By Country, 2018 (%)
Table 115: Europe Compounding Pharmacies Market, Country Share, 2018 (%)
7.5.3 Europe Compounding Pharmacies Market Size, By Country, 2024F (%)
Table 116: Europe Compounding Pharmacies Market, Country Share, 2024F (%)
7.5.4 Germany Compounding Pharmacies Market, By Value (2014-2018)
Table 117: Germany Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.5.5 Germany Compounding Pharmacies Market, By Value (2019-2024)
Table 118: Germany Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 119: Germany, Current Expenditure on Health (All Functions) as a share of GDP, 2014-2018
Table 120: Germany, Population ages 65 and above, 2012-2017 (% total)
Table 121: Prevalence of Different Type of Cancer in Germany in year 2016 & 2017 ( In Hundreds)
7.5.6 U.K Compounding Pharmacies Market, By Value (2014-2018)
Table 122: U.K Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.5.7 U.K Compounding Pharmacies Market, By Value (2019-2024)
Table 123: U.K Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 124: Cancer Statistics in the United Kingdom
Table 125: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Table 126: Prevalence of cardiovascular diseases in United Kingdom, In million
Table 127: U.K, Population Ages 65 and Above (% of total), 2012-2018
Table 128: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
7.6 APAC Compounding Pharmacies Market: Growth and Forecast
7.6.1 By Value (2014-2018)
Table 129: APAC Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.6.2 By Value (2019-2024)
Table 130: APAC Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 131: Population ages 65 and above, APAC Region, 2018 (% of total)
Table 132: Population ages 65 and above, APAC Region, By Select Country, 2050 (% of total)
Table 133: APAC - Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2017
Table 134: APAC - Obesity Rate, By Select Country, 2017 (In Percentage)
Table 135: East Asia and Pacific, Share of urban population, 2013-2018 (In %)
Table 136: Prevalence of cardiovascular diseases in APAC region, In million
Table 137: APAC, Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 138: Estimated number of deaths from prostate cancer in 2012 and 2030
7.6.3 APAC Compounding Pharmacies Market- Competitive Landscape
7.6.4 By Product Type, By Value (2014-2018)
Table 139: APAC Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
7.6.5 By Product Type, By Value (2019-2024)
Table 140: APAC Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
7.6.6 By Therapeutic Area, By Value (2014-2018)
Table 141: APAC Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
7.6.7 By Therapeutic Area, By Value (2019-2024)
Table 142: APAC Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
7.6.8 By End User, By Value (2014-2018)
Table 143: APAC Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
7.6.9 By End User, By Value (2019-2024)
Table 144: APAC Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
7.6 APAC Compounding Pharmacies Market: Country Analysis (India, China and Japan)
7.6.1 Market Attractiveness Chart of APAC Compounding Pharmacies Market – By Country, By Value
Table 145: Market Opportunity Chart of APAC Compounding Pharmacies Market - By Country, By Value (Year-2024)
7.6.2 APAC Compounding Pharmacies Market Size, By Country, 2018 (%)
Table 146: APAC Compounding Pharmacies Market, Country Share, 2018 (%)
7.6.3 APAC Compounding Pharmacies Market Size, By Country, 2024F (%)
Table 147: APAC Compounding Pharmacies Market, Country Share, 2024F (%)
7.6.4 India Compounding Pharmacies Market, By Value (2014-2018)
Table 148: India Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.6.5 India Compounding Pharmacies Market, By Value (2019-2024)
Table 149: India Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 150: India, Total Population, 2013-2023F (In Billion)
Table 151: India, Share of Urban Population, 2012-2018 (In %)
Table 152: India, GDP Growth Per Year, 2015-2019 (In %)
Table 153: India, Total deaths due to cancer, 2018
Table 154: Top 5 forms of cancer in men and women in India
Table 155: Population ages 65 and above, 2013-2018 (% of total)
Table 156: India, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
7.6.6 China Compounding Pharmacies Market, By Value (2014-2018)
Table 157: China Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.6.5 China Compounding Pharmacies Market, By Value (2019-2024)
Table 158: China Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 159: China, GDP Growth Per Year, 2015-2019 (In %)
Table 160: China, Total Population, 2013-2021F (In Billion)
Table 161: China, Share of Urban Population, 2012-2018 (In %)
Table 162: China, Adjusted net national income per capita (Current USD)
Table 163: China, Population ages 65 and above, 2013-2018 (% of total)
Table 164: Number of new cancer cases, Males (all ages), 2018 (In %)
Table 165: Number of new cancer cases, Females(all ages), 2018 (In %)
Table 166: Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds)
Table 167: China, Cancer Mortality Rate, By Cancer Site, 2018
7.6.6 Japan Compounding Pharmacies Market, By Value (2014-2018)
Table 168: Japan Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.6.7 Japan Compounding Pharmacies Market, By Value (2019-2024)
Table 169: Japan Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 170: Japan, Population ages 65 and above, 2012-2018 (% of total)
Table 171: Japan, GDP Growth Per Year, 2015-2019F (In %)
Table 172: Japan Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 173: Total Number of People With Cardiovascular Disorders in Japan, By Type, 2017 (In thousands)
Table 174: Prevalence of Different Type of Cancer in Japan in year 2016 & 2017 ( In Hundreds)
7.7 ROW Compounding Pharmacies Market: Growth and Forecast
7.7.1 By Value (2014-2018)
Table 175: ROW Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.7.2 By Value (2019-2024)
Table 176: ROW Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 177: North Africa and Middle East Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 178: Middle East and North Africa, GDP, 2012-2018 (In USD Trillion)
Table 179: ROW, Population ages 60 or above, By Select Country, 2050F (% of total)
Table 180: Population ages 65 and above, Middle East and North Africa Region, 2012-2018 (% of total)
Table 181: Population ages 65 and above, Latin America and Caribbean Region, 2012-2018 (% of total)
Table 182: Cancer Prevalence in MENA (% of total), 2018
Table 183: Top 10 fastest growing economies, 2018, (In%)
Table 184: Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds)
Table 185: Total Number of People With Cardiovascular Disorders in North Africa and Middle East, By Type, 2017 (In thousands)
7.7.3 ROW Compounding Pharmacies Market- Company Share Analysis
7.7.4 By Product Type, By Value (2014-2018)
Table 186: ROW Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
7.7.5 By Product Type, By Value (2019-2024)
Table 187: ROW Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
7.7.6 By Therapeutic Area, By Value (2014-2018)
Table 188: ROW Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
7.7.7 By Therapeutic Area, By Value (2019-2024)
Table 189: ROW Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
7.7.8 By End User, By Value (2014-2018)
Table 190: ROW Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
7.7.9 By End User, By Value (2019-2024)
Table 191: ROW Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
7.8 ROW Compounding Pharmacies Market: Country Analysis (Brazil and Mexico)
7.8.1 Market Attractiveness Chart of APAC Compounding Pharmacies Market – By Country, By Value
Table 192: Market Opportunity Chart of ROW Compounding Pharmacies Market - By Country, By Value (Year-2024)
7.8.2 ROW Compounding Pharmacies Market Size, By Country, 2018 (%)
Table 193: ROW Compounding Pharmacies Market, Country Share, 2018 (%)
7.8.3 ROW Compounding Pharmacies Market Size, By Country, 2024F (%)
Table 194: ROW Compounding Pharmacies Market, Country Share, 2024F (%)
7.8.4 Brazil Compounding Pharmacies Market, By Value (2014-2018)
Table 195: Brazil Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.8.5 Brazil Compounding Pharmacies Market, By Value (2019-2024)
Table 196: Brazil Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 197: Brazil Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 198: Total Number of People With Cardiovascular Disorders in Brazil, By Type,2017 (In thousands)
Table 199: Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds)
Table 200: Prevalence of cardiovascular disease in Brazil, In Billion
Table 201: Brazil health expenditure as a share of GDP, 2018
Table 202: Brazil, Population ages 65 and above, 2012-2018 (In Percentage)
7.8.6 Mexico Compounding Pharmacies Market, By Value (2014-2018)
Table 203: Mexico Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
7.8.7 Mexico Compounding Pharmacies Market, By Value (2019-2024)
Table 204: Mexico Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 205: Key Drivers of Compounding Pharmacies Market in Mexico
Table 206: Mexico, Compounding Pharmacies Market, Key Traits
Table 207: Mexico, Population ages 65 and above, 2012-2018 (In Percentage)
Table 208: FDA Compounding Inspection Activity, (As of June 2017)
8. Global Compounding Pharmacies Market Dynamics
8.1 Global Compounding Pharmacies Market Drivers
8.2 Global Compounding Pharmacies Market Restraints
9. Global Compounding Pharmacies Market Trends
10. Global Compounding Pharmacies Market Landscape
10.1 Competitive Landscape
10.2 Company Share Analysis
10.3 Merger and Acquisitions of Key Industry Players
11. Porter Five Force Analysis
12. SWOT Analysis
13. Policy and Regulatory Landscape
14. Company Profiles
14.1 Fagron
Table 209: Fagron, Business Verticals
Table 210: Fagron, Revenue, 2014-2018 (In USD Million)
Table 211: Fagron, Revenue, By Business Segment, 2018 (In %)
Table 212: Fagron, Net Sales, By Geographic Region, 2018 (In %)
14.2 PharMEDium
14.3 Doughtery’s Pharmacy
Table 213: Dougherty’s Pharmacy, Revenue, 2014-2018 (In USD Million)
14.4 ITC Compounding Pharmacy
14.5 Fresenius Kabi
Table 214: Fresenius Kabi, Revenue, 2015-2018 (USD Billion)
Table 215: Fresenius Kabi, By Product Group, 2018 (%)
Table 216: Fresenius Kabi, By Region, 2018 (%)
14.6 Clinigen Group
Table 217: Clinigen Group, Revenue, 2014-2018 (In USD Million)
Table 218: Clinigen Group, Revenue, By Business Segment, 2018 (In %)
Table 219: Clinigen Group, Adjusted Gross Profit, By Geographic Region, 2018 (In %)
Table 220: Clinigen Group, Adjusted Gross Profit, By Client/Customer, 2018 (In %)
14.7 Absolute Pharmacy
14.8 McGuff Compounding Pharmacies Services, Inc.
14.9 Pentec Health
14.10 Harrow Health, Inc.
Table 221: Harrow Health, Inc., Revenue, 2014-2018 (In USD Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook